Arch Venture Partners Xii, Llc Neumora Therapeutics, Inc. (NMRA) insider trading activity

ARCH Venture Partners XII, LLC Transaction History

Date	Transaction	Value	Shares Traded
Dec 08 2023	BUY Other acquisition or disposition	-	1,879,654
Nov 14 2023	BUY Open market or private purchase	$40,216 $11.98 p/Share	3,357
Nov 13 2023	BUY Open market or private purchase	$371,922 $11.75 p/Share	31,653
Nov 10 2023	BUY Open market or private purchase	$199,699 $11.56 p/Share	17,275
Nov 09 2023	BUY Open market or private purchase	$327,261 $10.53 p/Share	31,079
Nov 08 2023	BUY Open market or private purchase	$1,041,513 $11.29 p/Share	92,251
Nov 07 2023	BUY Open market or private purchase	$347,208 $11.5 p/Share	30,192
Nov 06 2023	BUY Open market or private purchase	$497,597 $11.55 p/Share	43,082
Nov 03 2023	BUY Open market or private purchase	$255,139 $11.38 p/Share	22,420
Sep 29 2023	BUY Open market or private purchase	$483,148 $13.98 p/Share	34,560
Sep 28 2023	BUY Open market or private purchase	$561,304 $13.38 p/Share	41,951
Sep 27 2023	BUY Open market or private purchase	$301,644 $12.31 p/Share	24,504
Sep 26 2023	BUY Open market or private purchase	$398,820 $11.73 p/Share	34,000
Sep 25 2023	BUY Open market or private purchase	$682,110 $11.23 p/Share	60,740
Sep 22 2023	BUY Open market or private purchase	$445,600 $11.14 p/Share	40,000

PRME

Prime Medicine, Inc.

> 10% Shareholder

RAPP

Rapport Therapeutics, Inc.

AVP

> 10% Shareholder

Chicago, IL

Receive a notification when an Institution or Guru buys or sells NMRA shares.

Notify only if

Value

Get notified when an Neumora Therapeutics, Inc. insider buys or sells NMRA shares.

Notify only if

Operation

Value

Type

Receive news related to Neumora Therapeutics, Inc.